Pharma in silica
Quebec
About Pharma in silica
Pharma in Silica develops pharmaceuticals in the preclinical stage. Pharma in Silica is now working on the regulatory applications for a multi-center Canada/US clinical trial for patients with advanced non-small cell lung cancer (NSCLC) as well as the preclinical safety and efficacy investigation of OpPacli.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $3.0M
- Last round: Undisclosed (Oct 2024)
- Website: pharma-insilica.com
- Phone: 418.874.0054
Industries & Categories
Health Care, Medical, Pharmaceutical
Canonical: https://fsome.com/organization/pharma-in-silica-73473 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.